Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Cytometry B Clin Cytom. 2012 Feb 14;82(3):158–172. doi: 10.1002/cyto.b.21007

Table 4A.

Modulators and technical conditions.

Modulator Final Concentration Modulator Treatment Duration Manufacturer (Location)
Ara-C 0.5 μg/mL 24 hours Sigma Aldrich (St Louis, MO)
Daunorubicin 100 ng/mL 24 hours Sigma Aldrich (St Louis, MO)
Etoposide 30 μg/mL 24 hours Sigma Aldrich (St Louis, MO)
FLT3L 50 ng/mL 15 mins R&D (Minneapolis, MN)
G-CSF 50 ng/mL 15 mins R&D (Minneapolis, MN)
Hydrogen Peroxide 3.0 mM 15 mins JT Baker (Phillipsburg, NJ)
IL-27 50 ng/mL 15 mins R&D (Minneapolis, MN)
PMA 400 nM 15 mins Sigma Aldrich (St Louis, MO)
SCF 20 ng/mL 15 mins R&D (Minneapolis, MN)